BBNX BBNX R2K
$12.12
-29.70% 1Y
Market & Price
Market Cap
-
Current Price
$12.12
High / Low (52W)
$31.99 / $8.86
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-24.07%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.49
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$328.74M
Current Assets
$267.90M
Working Capital
$236.98M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
724.29%
Profit 5Y
-4.35%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- Compounding revenue at 724.3% over 5 years.
CONS
- Earnings shrank at -4.3% CAGR over 5 years.
- Trading 62.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.93M | 15.05M | - | - | 17.64M | 23.24M | 27.25M | 32.12M | 27.63M |
| Cost of Revenue | - | - | - | - | 8.67M | 10.73M | 12.13M | 13.18M | 11.19M |
| Gross Profit | 7.20M | 8.08M | - | - | 8.97M | 12.50M | 15.12M | 18.94M | 16.44M |
| Operating Expenses | - | - | - | - | 27.61M | 32.38M | 32.16M | 35.07M | 40.71M |
| Operating Income | -9.45M | -11.78M | - | - | -18.64M | -19.87M | -17.04M | -16.12M | -24.27M |
| EBITDA | - | - | - | - | -18.04M | -19.22M | -16.36M | -11.01M | -23.28M |
| Interest Expense | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | -28.66M | -16.87M | -14.21M | -13.47M | -21.89M |
| Tax Provision | - | - | - | - | - | - | - | - | - |
| Net Income | -12.45M | -14.46M | - | - | -28.66M | -16.87M | -14.21M | -13.47M | -21.89M |
| Diluted EPS | -2.07 | -2.37 | - | - | -0.93 | -0.39 | -0.33 | -0.30 | -0.49 |
| R&D Expense | 5.48M | 6.35M | 5.14M | - | 7.59M | 8.87M | 8.20M | - | 10.36M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 179.00K | 11.99M | 65.12M | 100.25M |
| Cost of Revenue | - | 5.69M | 29.24M | 44.71M |
| Gross Profit | 179.00K | 6.31M | 35.89M | 55.54M |
| Operating Expenses | 66.02M | 42.16M | 81.14M | 127.22M |
| Operating Income | -65.84M | -35.85M | -45.25M | -71.68M |
| EBITDA | -62.65M | -33.76M | -42.97M | -68.81M |
| Interest Expense | 14.00K | 68.00K | - | - |
| Pretax Income | -64.75M | -44.10M | -54.76M | -73.20M |
| Tax Provision | - | - | - | - |
| Net Income | -64.75M | -44.10M | -54.76M | -73.20M |
| Diluted EPS | -2.12 | -1.45 | -1.28 | -1.81 |
| R&D Expense | - | 17.94M | 26.18M | 34.79M |
Compounded Sales Growth
| 5 Years: | 724.29% |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -4.35% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -29.70% |
| 6 Months: | -61.54% |
| 3 Months: | -4.04% |
| 1 Month: | +22.42% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 35.53M | 110.04M | 149.65M | 328.74M |
| Current Assets | 28.47M | 103.62M | 132.92M | 267.90M |
| Cash & Equivalents | 27.68M | 26.57M | 30.43M | 31.58M |
| Inventory | 0 | 1.25M | 13.32M | 21.72M |
| Receivables | 0 | 4.45M | 12.00M | 17.12M |
| Total Liabilities | 205.56M | 313.14M | 395.00M | 41.13M |
| Current Liabilities | 8.87M | 10.61M | 21.15M | 30.92M |
| Long Term Debt | - | - | - | - |
| Total Debt | 4.13M | 4.22M | 7.25M | 7.30M |
| Total Equity | -170.03M | -203.10M | -245.36M | 287.61M |
| Shares Outstanding | 42.86M | 42.86M | 42.86M | 44.36M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -60.21M | -32.45M | -48.27M | -50.92M |
| Investing Cash Flow | -769.00K | -69.69M | -3.48M | -162.81M |
| Financing Cash Flow | 56.78M | 101.03M | 55.62M | 214.87M |
| Capital Expenditure | -772.00K | -402.00K | -3.40M | -5.30M |
| Free Cash Flow | -60.98M | -32.85M | -51.67M | -56.22M |
| Net Change in Cash | -4.20M | -1.11M | 3.87M | 1.14M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 100.0% | 52.6% | 55.1% | 55.4% |
| Operating Margin % | -36,784.4% | -298.9% | -69.5% | -71.5% |
| Net Margin % | -36,173.7% | -367.6% | -84.1% | -73.0% |
| ROE % | 38.1% | 21.7% | 22.3% | -25.5% |
| ROCE % | -247.0% | -36.1% | -35.2% | -24.1% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BBNX
No recent headlines available.